Cargando…
Targeting Mitochondria by Plant Secondary Metabolites: A Promising Strategy in Combating Parkinson’s Disease
Parkinson’s disease (PD) is one of the most prevalent and debilitating neurodegenerative conditions, and is currently on the rise. Several dysregulated pathways are behind the pathogenesis of PD; however, the critical targets remain unclear. Accordingly, there is an urgent need to reveal the key dys...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619002/ https://www.ncbi.nlm.nih.gov/pubmed/34830453 http://dx.doi.org/10.3390/ijms222212570 |
_version_ | 1784604884196130816 |
---|---|
author | Fakhri, Sajad Abdian, Sadaf Zarneshan, Seyede Nazanin Akkol, Esra Küpeli Farzaei, Mohammad Hosein Sobarzo-Sánchez, Eduardo |
author_facet | Fakhri, Sajad Abdian, Sadaf Zarneshan, Seyede Nazanin Akkol, Esra Küpeli Farzaei, Mohammad Hosein Sobarzo-Sánchez, Eduardo |
author_sort | Fakhri, Sajad |
collection | PubMed |
description | Parkinson’s disease (PD) is one of the most prevalent and debilitating neurodegenerative conditions, and is currently on the rise. Several dysregulated pathways are behind the pathogenesis of PD; however, the critical targets remain unclear. Accordingly, there is an urgent need to reveal the key dysregulated pathways in PD. Prevailing reports have highlighted the importance of mitochondrial and cross-talked mediators in neurological disorders, genetic changes, and related complications of PD. Multiple pathophysiological mechanisms of PD, as well as the low efficacy and side effects of conventional neuroprotective therapies, drive the need for finding novel alternative agents. Recently, much attention has been paid to using plant secondary metabolites (e.g., flavonoids/phenolic compounds, alkaloids, and terpenoids) in the modulation of PD-associated manifestations by targeting mitochondria. In this line, plant secondary metabolites have shown promising potential for the simultaneous modulation of mitochondrial apoptosis and reactive oxygen species. This review aimed to address mitochondria and multiple dysregulated pathways in PD by plant-derived secondary metabolites. |
format | Online Article Text |
id | pubmed-8619002 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86190022021-11-27 Targeting Mitochondria by Plant Secondary Metabolites: A Promising Strategy in Combating Parkinson’s Disease Fakhri, Sajad Abdian, Sadaf Zarneshan, Seyede Nazanin Akkol, Esra Küpeli Farzaei, Mohammad Hosein Sobarzo-Sánchez, Eduardo Int J Mol Sci Review Parkinson’s disease (PD) is one of the most prevalent and debilitating neurodegenerative conditions, and is currently on the rise. Several dysregulated pathways are behind the pathogenesis of PD; however, the critical targets remain unclear. Accordingly, there is an urgent need to reveal the key dysregulated pathways in PD. Prevailing reports have highlighted the importance of mitochondrial and cross-talked mediators in neurological disorders, genetic changes, and related complications of PD. Multiple pathophysiological mechanisms of PD, as well as the low efficacy and side effects of conventional neuroprotective therapies, drive the need for finding novel alternative agents. Recently, much attention has been paid to using plant secondary metabolites (e.g., flavonoids/phenolic compounds, alkaloids, and terpenoids) in the modulation of PD-associated manifestations by targeting mitochondria. In this line, plant secondary metabolites have shown promising potential for the simultaneous modulation of mitochondrial apoptosis and reactive oxygen species. This review aimed to address mitochondria and multiple dysregulated pathways in PD by plant-derived secondary metabolites. MDPI 2021-11-22 /pmc/articles/PMC8619002/ /pubmed/34830453 http://dx.doi.org/10.3390/ijms222212570 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Fakhri, Sajad Abdian, Sadaf Zarneshan, Seyede Nazanin Akkol, Esra Küpeli Farzaei, Mohammad Hosein Sobarzo-Sánchez, Eduardo Targeting Mitochondria by Plant Secondary Metabolites: A Promising Strategy in Combating Parkinson’s Disease |
title | Targeting Mitochondria by Plant Secondary Metabolites: A Promising Strategy in Combating Parkinson’s Disease |
title_full | Targeting Mitochondria by Plant Secondary Metabolites: A Promising Strategy in Combating Parkinson’s Disease |
title_fullStr | Targeting Mitochondria by Plant Secondary Metabolites: A Promising Strategy in Combating Parkinson’s Disease |
title_full_unstemmed | Targeting Mitochondria by Plant Secondary Metabolites: A Promising Strategy in Combating Parkinson’s Disease |
title_short | Targeting Mitochondria by Plant Secondary Metabolites: A Promising Strategy in Combating Parkinson’s Disease |
title_sort | targeting mitochondria by plant secondary metabolites: a promising strategy in combating parkinson’s disease |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619002/ https://www.ncbi.nlm.nih.gov/pubmed/34830453 http://dx.doi.org/10.3390/ijms222212570 |
work_keys_str_mv | AT fakhrisajad targetingmitochondriabyplantsecondarymetabolitesapromisingstrategyincombatingparkinsonsdisease AT abdiansadaf targetingmitochondriabyplantsecondarymetabolitesapromisingstrategyincombatingparkinsonsdisease AT zarneshanseyedenazanin targetingmitochondriabyplantsecondarymetabolitesapromisingstrategyincombatingparkinsonsdisease AT akkolesrakupeli targetingmitochondriabyplantsecondarymetabolitesapromisingstrategyincombatingparkinsonsdisease AT farzaeimohammadhosein targetingmitochondriabyplantsecondarymetabolitesapromisingstrategyincombatingparkinsonsdisease AT sobarzosanchezeduardo targetingmitochondriabyplantsecondarymetabolitesapromisingstrategyincombatingparkinsonsdisease |